[A report of two endometrial cancer cases in that low-dose aspirin was effective for hypercoagulopathy caused by medroxyprogesterone acetate].
Sato
K
K
Department of Obstetrics and Gynecology, School of Medicine, Sapporo Medical University.
Mori
Y
Y
Okamura
N
N
Mizuuchi
H
H
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D001241:Aspirin / Q000008:administration & dosage*; D018284:Cystadenocarcinoma, Serous / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects*; D008875:Middle Aged; D013927:Thrombosis / Q000139:chemically induced* / Q000188:drug therapy*
D017258:Medroxyprogesterone Acetate; D001241:Aspirin